Non-small cell lung cancer stage IIIA – Basic Information

Go back

Stage IIIA non-small cell lung cancer represents a complex form of lung cancer where the disease has begun to spread beyond the lungs to nearby tissues or lymph nodes, but has not yet reached distant parts of the body. This stage affects roughly 30% of people diagnosed with non-small cell lung cancer and requires careful evaluation by a multidisciplinary team to determine the best treatment approach.

Understanding Stage IIIA Non-Small Cell Lung Cancer

Stage IIIA non-small cell lung cancer is part of a broader category known as locally advanced cancer, meaning the disease has spread beyond its original location but remains within the chest area[3][4]. This stage is particularly challenging because it sits between early-stage disease that can often be removed with surgery alone and advanced cancer that has spread to distant organs throughout the body.

What makes stage IIIA disease especially complex is its heterogeneity. The stage includes a wide range of situations, from small tumors that have spread to specific lymph nodes, to larger tumors that have grown into nearby structures like the chest wall or diaphragm[6]. This variety means that two people with stage IIIA disease might have very different cancer presentations and require different treatment strategies.

The staging system divides stage IIIA into multiple subcategories based on tumor size, location, and whether cancer cells have reached the lymph nodes—small bean-shaped structures that are part of the body’s immune system[3]. In stage IIIA, cancer may have spread to lymph nodes on the same side of the chest where the tumor originated, or the tumor itself may have grown larger and invaded surrounding tissues.

⚠️ Important
Stage IIIA non-small cell lung cancer requires evaluation by a team of specialists including medical oncologists, radiation oncologists, thoracic surgeons, and lung specialists. Treatment decisions should always be made through multidisciplinary discussions in specialized centers with experience in treating lung cancer[6].

How Common Is Stage IIIA Non-Small Cell Lung Cancer

Non-small cell lung cancer is the most common type of lung cancer, accounting for approximately 80% to 85% of all lung cancer cases[21]. Among people diagnosed with non-small cell lung cancer, about 30% are found to have stage III disease at the time of diagnosis[4][19]. This means that a substantial portion of lung cancer patients face the challenges associated with locally advanced disease.

Lung cancer remains the second most commonly diagnosed cancer worldwide and continues to be the leading cause of cancer-related deaths[5][8]. The high mortality rate is partly because many cases are not detected until the cancer has already progressed to advanced stages like stage IIIA, when treatment becomes more complex.

The majority of people diagnosed with stage IIIA disease have what doctors call unresectable cancer, meaning the tumor cannot be safely or completely removed through surgery[4]. This is often because the cancer has grown into critical structures in the chest, such as major blood vessels, nerves, or the heart, making surgical removal too risky or impossible without causing serious harm.

What Causes Non-Small Cell Lung Cancer

The development of non-small cell lung cancer occurs when normal cells in the lungs undergo changes that cause them to grow and divide uncontrollably. While medical experts understand the mechanisms of how cancer develops, they do not always know exactly why it happens in specific individuals[21].

The most significant risk factor for developing lung cancer is tobacco smoking, including cigarettes, pipes, and cigars[10][21]. Smoking-related lung cancer development is a multistep process that can cause the cells lining the airways to undergo a series of changes—from abnormal growth patterns to precancerous changes, and eventually to invasive cancer[10].

However, smoking is not the only cause. Exposure to secondhand smoke can also increase the risk of developing lung cancer, even in people who have never smoked themselves[10]. Additionally, occupational exposures to certain substances play a role. Workers exposed to asbestos, arsenic, chromium, beryllium, nickel, and other hazardous materials face elevated risks[10].

Environmental factors also contribute to lung cancer risk. Radon, a naturally occurring radioactive gas that can accumulate in homes and workplaces, is a recognized cause of lung cancer[10]. People who have received radiation therapy to the breast or chest for other medical conditions may also have an increased risk of developing lung cancer later in life[10].

Who Is at Higher Risk

The most important risk factor for most cancers, including lung cancer, is increasing age[10]. As people get older, their risk of developing cancer generally increases. This relationship between age and cancer risk reflects the accumulated exposure to risk factors over time and changes in how cells function as the body ages.

A person’s smoking history significantly influences their risk. This includes not only current smokers but also former smokers, as the damage from tobacco smoke can persist for years after someone quits. The duration of smoking and the amount smoked both affect the level of risk. Someone who smoked heavily for many years faces a higher risk than someone who smoked lightly for a shorter period.

Family history can also play a role in lung cancer risk[21]. People who have close relatives with lung cancer may be at somewhat higher risk themselves, although the exact reasons for this are not always clear. It may involve a combination of shared environmental exposures and inherited genetic factors.

People with certain existing respiratory conditions, such as chronic obstructive pulmonary disease (COPD)—a group of lung diseases that cause breathing difficulties—or pulmonary fibrosis—scarring of lung tissue—may also have increased lung cancer risk[21]. These conditions often share risk factors with lung cancer, particularly smoking.

Recognizing Symptoms

Non-small cell lung cancer may not cause noticeable symptoms in its early stages. However, as the disease progresses to stage IIIA, symptoms typically become more apparent. Understanding these signs can help people recognize when they need medical attention, though these symptoms can also be caused by many conditions other than cancer.

A chronic cough that persists or worsens over time is one of the most common symptoms[21]. This is not just any temporary cough from a cold or minor illness, but rather a cough that lasts for weeks or months and may change in character. Some people notice that their cough becomes more frequent, produces different amounts of mucus, or develops a different sound.

Coughing up blood, even in small amounts, is a symptom that should never be ignored[21]. The blood may appear as streaks in mucus or as larger amounts. This happens when the tumor grows into airways or blood vessels in the lungs, causing bleeding. While this symptom can be frightening, it is important to seek medical evaluation promptly.

Shortness of breath or difficulty breathing becomes more common as lung cancer advances[21]. People may notice they become winded more easily during activities they previously handled without difficulty. This occurs because the tumor may be blocking airways, causing fluid to accumulate around the lungs, or reducing the amount of healthy lung tissue available for breathing.

Chest pain is another frequent symptom[21]. The discomfort may be constant or come and go, and it might worsen with deep breathing, coughing, or laughing. The pain can indicate that the cancer has grown into the chest wall or the membrane surrounding the lungs. In stage IIIA disease, where cancer may have spread to nearby structures, chest pain can be particularly significant.

Other symptoms include hoarseness or changes in voice, which may occur if the tumor affects the nerves controlling the voice box[21]. Wheezing—a whistling sound when breathing—can develop if airways become partially blocked. Many people also experience loss of appetite and unexplained weight loss, along with persistent tiredness that does not improve with rest[21].

Prevention Strategies

While not all cases of lung cancer can be prevented, there are several important steps that can significantly reduce risk. The most effective prevention strategy is avoiding tobacco use. For people who have never smoked, not starting is crucial. For current smokers, quitting smoking is the single most important action they can take to reduce their lung cancer risk.

Quitting smoking benefits people at any age and at any point in their smoking history. Even people who have smoked for many years can reduce their risk by stopping. The body begins to repair some of the damage caused by smoking relatively quickly after quitting, and the risk of lung cancer continues to decrease over time, though it may never return to the level of someone who never smoked.

Avoiding exposure to secondhand smoke is also important for prevention[10]. People should try to avoid environments where others are smoking and advocate for smoke-free spaces in their homes, workplaces, and public areas. This protects not only individuals who have never smoked but also helps those who have quit avoid relapse triggers.

Testing homes for radon and taking steps to reduce radon levels when they are elevated can help prevent radon-related lung cancer[10]. Radon is invisible and odorless, so testing is the only way to know if levels are dangerous. If high radon levels are detected, specialized contractors can install systems to reduce radon accumulation in homes.

People who work in occupations with exposure to lung cancer-causing substances should follow all safety protocols and use appropriate protective equipment[10]. This includes wearing respirators when required, following proper handling procedures for hazardous materials, and participating in workplace health monitoring programs. Employers have responsibilities to minimize these exposures, and workers should be informed about potential risks.

For individuals at high risk due to heavy smoking history, lung cancer screening may be appropriate. Screening involves regular imaging tests to look for lung cancer before symptoms develop, when it may be easier to treat. However, screening is not right for everyone, and people should discuss with their healthcare providers whether screening is appropriate for their individual situation.

What Happens in the Body

Understanding what happens in the body during stage IIIA non-small cell lung cancer helps explain why symptoms occur and how treatments work. The disease represents a series of changes from normal lung function to cancer growth and spread.

Non-small cell lung cancer arises from the epithelial cells that line the airways and air sacs of the lungs[10]. Different types of non-small cell lung cancer originate from different parts of the lung structure. Squamous cell carcinoma typically starts in cells lining the larger airways near the center of the chest. Adenocarcinoma usually begins in cells in the outer portions of the lungs that produce mucus. Large cell carcinoma can develop in any part of the lung.

As cancer cells multiply, they form a tumor that gradually grows larger. In stage IIIA disease, this growth has progressed to the point where the tumor may be several centimeters in size, or multiple nodules may have formed in the same lobe of the lung[3]. The tumor may grow into nearby structures such as the chest wall, the diaphragm—the muscle that helps with breathing—or even the outer layers of the heart.

One of the defining characteristics of stage IIIA disease is the spread of cancer cells to lymph nodes. The lymphatic system is a network of vessels and nodes throughout the body that helps fight infection and remove waste. Cancer cells can break away from the original tumor and travel through lymphatic vessels to nearby lymph nodes[3]. In stage IIIA, cancer has typically reached lymph nodes in the mediastinum—the space between the lungs—on the same side of the chest as the tumor.

As the tumor grows, it can cause physical blockages in the airways, leading to collapsed lung tissue or infection in the blocked area. This explains why people with stage IIIA disease often experience coughing and shortness of breath. If the tumor invades blood vessels, it can cause bleeding, which leads to coughing up blood. Growth into the chest wall or the membrane surrounding the lungs causes pain because these structures have nerve endings.

The cancer may also affect nearby nerves, causing various symptoms depending on which nerves are involved. If the tumor grows into or presses on the nerve that controls the diaphragm, it can affect breathing. If it affects the nerve going to the voice box, it causes hoarseness. These complications arise because stage IIIA represents locally advanced disease where the cancer has begun to invade beyond the lung itself.

⚠️ Important
Stage IIIA non-small cell lung cancer is highly heterogeneous, with survival rates varying significantly based on specific tumor characteristics and lymph node involvement. Reported five-year survival rates range from approximately 5% in patients with bulky lymph node disease to 50% in selected patients with certain tumor types[6]. Individual prognosis depends on many factors and should be discussed with your healthcare team.

Ongoing Clinical Trials on Non-small cell lung cancer stage IIIA

  • Testing MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment

    Recruiting

    3 1 1 1
    Austria Belgium Czechia France Germany Greece +7
  • Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

    Recruiting

    4 1 1 1
    Belgium Bulgaria France Germany Hungary Italy +3
  • Study of Durvalumab with chemotherapy (paclitaxel, cisplatin, carboplatin, vinorelbine) in patients with stage IIIA/B non-small cell lung cancer that can be removed by surgery

    Recruiting

    2 1 1 1
    Germany
  • Study on the Effects of Adding Durvalumab After Chemotherapy and Surgery in Patients with Resectable Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Austria Belgium Estonia France Ireland Italy +1
  • Study of Volrustomig and Drug Combination for Patients with Early-stage Resectable Non-small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Belgium France Hungary Ireland Italy Portugal +1
  • Study on Durvalumab with Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer Patients

    Recruiting

    3 1 1 1
    Investigated drugs:
    The Netherlands
  • Study on Preoperative Treatment with Amivantamab, Carboplatin, and Pemetrexed for Patients with Resectable Non-Small-Cell Lung Cancer with EGFR Mutations

    Recruiting

    2 1 1 1
    Investigated drugs:
    Belgium Germany The Netherlands
  • Study of sacituzumab govitecan and zimberelimab treatment before and after surgery for patients with resectable non-small cell lung cancer

    Not yet recruiting

    2 1 1 1
    Germany
  • Study on Pembrolizumab as Maintenance Therapy for Patients with Unresectable Stage III Non-Small Cell Lung Cancer After Chemo-Radiotherapy

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    Italy
  • Study on Thoracic Radiotherapy and Durvalumab for Elderly or Frail Stage III Non-Small Cell Lung Cancer Patients Unable to Undergo Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Germany

References

https://www.cancer.gov/publications/dictionaries/cancer-terms/def/stage-iiia-non-small-cell-lung-cancer

https://www.vacancer.com/cancer/lung-cancer/non-small-cell-lung-cancer/stage-iiia-non-small-cell-lung-cancer/

https://www.cancerresearchuk.org/about-cancer/lung-cancer/stages-types/stage-3

https://www.imfinzi.com/stage-3-nsclc/about-nsclc/what-is-nsclc.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC10047909/

https://ccts.amegroups.org/article/view/45172/html

https://www.cancer.org/cancer/types/lung-cancer/detection-diagnosis-staging/staging-nsclc.html

https://pmc.ncbi.nlm.nih.gov/articles/PMC10047909/

https://www.cancer.org/cancer/types/lung-cancer/treating-non-small-cell/by-stage.html

https://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq

https://www.explorationpub.com/Journals/etat/Article/1002206

https://ccts.amegroups.org/article/view/41755/html

https://pubmed.ncbi.nlm.nih.gov/17873172/

https://www.vacancer.com/cancer/lung-cancer/non-small-cell-lung-cancer/stage-iiia-non-small-cell-lung-cancer/

https://cancer.ca/en/cancer-information/cancer-types/lung/treatment/stage-3

https://www.lungcancergroup.com/lung-cancer/stages/stage-3/

https://pmc.ncbi.nlm.nih.gov/articles/PMC10047909/

https://www.cancer.gov/types/lung/patient/non-small-cell-lung-treatment-pdq

https://www.imfinzi.com/stage-3-nsclc/about-nsclc/what-is-nsclc.html

https://www.cancercare.org/questions/35

https://my.clevelandclinic.org/health/diseases/6203-non-small-cell-lung-cancer

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

https://www.roche.com/stories/terminology-in-diagnostics

FAQ

What does stage IIIA non-small cell lung cancer mean?

Stage IIIA non-small cell lung cancer means the cancer has spread beyond the lungs to nearby lymph nodes or structures in the chest, but has not reached distant organs. It is considered locally advanced cancer. The cancer may have grown into the chest wall, diaphragm, or other nearby tissues, or spread to lymph nodes in the mediastinum on the same side as the tumor[3][4].

Can stage IIIA non-small cell lung cancer be treated?

Yes, stage IIIA non-small cell lung cancer can be treated, though it is more challenging than earlier stages. Treatment options may include chemotherapy, radiation therapy, surgery, targeted therapy, or combinations of these approaches. The specific treatment plan depends on the exact tumor characteristics, lymph node involvement, overall health, and whether the cancer can be removed surgically[15][9].

What does unresectable stage IIIA lung cancer mean?

Unresectable means the cancer cannot be safely or completely removed through surgery. This is common in stage IIIA disease and occurs when the tumor has grown into critical structures like major blood vessels, nerves, the heart, or other organs in the chest. The majority of people with stage III non-small cell lung cancer have unresectable disease[4][19].

Is stage IIIA lung cancer the same for everyone?

No, stage IIIA is very heterogeneous and includes many different disease presentations. It can range from small tumors with specific lymph node involvement to larger tumors invading chest structures. This variety means treatment approaches, prognosis, and survival rates differ significantly between patients, which is why multidisciplinary evaluation by specialists is essential[6][13].

How is stage IIIA different from stage IIIB lung cancer?

Stage IIIA and stage IIIB differ primarily in tumor size and the extent of lymph node involvement. Stage IIIA typically involves cancer spread to lymph nodes on the same side of the chest as the tumor. Stage IIIB involves spread to lymph nodes on the opposite side of the chest, in the neck, or above the collarbone, or larger tumors that have grown extensively into chest structures[3][19].

🎯 Key takeaways

  • Stage IIIA non-small cell lung cancer affects about 30% of people diagnosed with stage III disease and represents locally advanced cancer that has not spread to distant organs[4].
  • This stage includes very different disease presentations ranging from small tumors with lymph node involvement to larger tumors invading chest structures, making each case unique[6].
  • Smoking remains the most significant risk factor for lung cancer, but the disease can also develop in people who never smoked, particularly adenocarcinoma type[10].
  • Many people with stage IIIA disease have unresectable cancer, meaning surgery cannot safely remove the tumor because it has grown into critical structures in the chest[4].
  • Treatment decisions should be made by multidisciplinary teams including thoracic surgeons, medical oncologists, radiation oncologists, and lung specialists in high-volume centers[6].
  • Common symptoms include chronic cough, shortness of breath, chest pain, coughing up blood, and hoarseness, though some people may not have noticeable symptoms[21].
  • Five-year survival rates for stage IIIA disease vary widely from 5% to 50% depending on specific tumor characteristics and treatment response[6].
  • Treatment options may include chemotherapy, radiation therapy, surgery, targeted therapy, or immunotherapy in various combinations depending on individual circumstances[15].